Overview
Primary squamous cell carcinoma (SCC) of the lip is a malignant neoplasm arising from the squamous epithelium lining the oral cavity, predominantly affecting the lower lip due to higher sun exposure. This condition is clinically significant due to its potential for local invasion and metastasis, particularly if not diagnosed and treated early. It primarily affects middle-aged to elderly individuals, with a slight male predominance. Understanding and managing this condition is crucial in day-to-day practice for plastic surgeons and oncologists to ensure optimal functional and aesthetic outcomes post-treatment 123.Pathophysiology
Primary SCC of the lip develops through a series of genetic and molecular alterations that disrupt normal cellular regulation. Chronic exposure to ultraviolet (UV) radiation plays a pivotal role, inducing mutations in key genes such as TP53 and CDKN2A, leading to uncontrolled cell proliferation and loss of apoptosis mechanisms. These genetic changes often occur within the basal layer of the epithelium, where squamous cells are most susceptible to UV damage. Over time, these alterations promote the transformation of normal keratinocytes into malignant cells, characterized by invasive growth patterns and potential lymphatic spread 23.Epidemiology
The incidence of primary SCC of the lip varies geographically, with higher rates observed in regions with greater UV exposure, such as southern Europe and North America. Globally, it constitutes a small but significant proportion of head and neck cancers, accounting for approximately 10-20% of oral cavity malignancies. Age is a notable risk factor, with peak incidence occurring in individuals over 60 years old. Males are affected more frequently than females, with a male-to-female ratio ranging from 2:1 to 4:1. Additionally, fair skin and tobacco use are recognized risk factors, contributing to the overall burden of this disease 34.Clinical Presentation
Patients with primary SCC of the lip often present with non-healing ulcers or persistent sores that may bleed easily, typically located on the lower lip due to greater sun exposure. Other common symptoms include pain, swelling, and changes in lip color or texture. Atypical presentations might include asymptomatic lesions or those mimicking benign conditions like actinic cheilitis. Red-flag features include rapid growth, ulceration, induration, and involvement of deeper structures, which necessitate urgent evaluation to rule out advanced disease 35.Diagnosis
The diagnostic approach for primary SCC of the lip involves a combination of clinical examination, histopathological analysis, and imaging studies when necessary. Key diagnostic criteria include:Clinical Examination: Detailed inspection for ulceration, induration, and irregular borders.
Biopsy: Definitive diagnosis through incisional or excisional biopsy with histopathological examination.
Histopathological Findings: Presence of malignant squamous cells with keratinization, nuclear pleomorphism, and abnormal mitotic figures.
Special Stains: Periodic acid-Schiff (PAS) staining may help differentiate from other epithelial malignancies.
Imaging: CT or MRI scans for assessing local extent and potential lymph node involvement if clinical suspicion is high.
Differential Diagnosis:
- Actinic Cheilitis: Typically presents with hyperkeratosis and dysplasia without invasive features.
- Pyogenic Granuloma: Usually presents as a rapidly growing, soft, red, and sometimes bleeding mass.
- Basal Cell Carcinoma: Less aggressive, often presents as pearly papules with rolled borders and telangiectasia 35.Management
Surgical Management
Primary Tumor Resection:
- Vermilionectomy: Wide excision of the tumor with a safety margin, often extending into the adjacent skin.
- Margins: Ensuring clear margins (typically ≥ 2 mm) to minimize recurrence risk 35.
Reconstructive Techniques:
- Free Flaps: Utilization of flaps like radial forearm free flap with innervated pronator quadratus for functional and aesthetic outcomes (e.g., in large defects) 2.
- Facial Artery Perforator (FAP) Flaps: Sparing the orbicularis oris muscle to preserve function 3.
- Cross-Lip Flap: For vermilion defects, ensuring vascular integrity and minimizing donor site morbidity 4.
- Direct Closure: Suitable for smaller defects without undermining to reduce complications 5.Adjuvant Therapy
Radiation Therapy:
- Indications: For high-risk features such as deep invasion, lymphovascular emboli, or positive margins post-resection.
- Dose and Schedule: Typically 60-70 Gy over 6-7 weeks 3.Chemotherapy:
- Role: Limited in primary lip SCC, often reserved for advanced or metastatic disease.
- Combination Therapy: May be considered in specific cases under specialist guidance 3.Monitoring and Follow-Up
Regular Examinations: Every 3-6 months for the first 2 years, then annually.
Imaging: Periodic imaging if high-risk features are present.
Biopsies: Any suspicious changes warrant prompt biopsy 3.Complications
Postoperative Complications: Infection, flap failure, delayed wound healing, and sensory disturbances.
Long-term Complications: Dysfunctional oral competence, cosmetic deformities, and potential recurrence.
Management Triggers: Early signs include fever, purulent drainage, or flap dehiscence; prompt referral to a specialist is advised 235.Prognosis & Follow-up
The prognosis for primary SCC of the lip is generally favorable when diagnosed and treated early, with 5-year survival rates often exceeding 80%. Prognostic indicators include tumor size, depth of invasion, nodal involvement, and adequacy of surgical margins. Recommended follow-up intervals include:
Initial Postoperative Period: Frequent visits (weekly to monthly) for the first 6 months.
Long-term Monitoring: Every 6-12 months for the first 5 years, then annually thereafter.
Screening Tools: Regular clinical examinations, imaging if indicated, and patient education on self-examination 35.Special Populations
Elderly Patients: Higher risk of complications; tailored surgical approaches and close monitoring are essential 3.
Pediatrics: Rare but requires multidisciplinary care due to unique developmental considerations 3.
Comorbidities: Patients with chronic conditions like diabetes or immunosuppression may require adjusted treatment protocols to manage increased risks of complications 3.Key Recommendations
Early Diagnosis and Wide Resection: Perform wide local excision with clear margins to ensure optimal outcomes (Evidence: Strong 3).
Preservation of Orbicularis Oris Muscle: When feasible, preserve the orbicularis oris muscle to maintain functional outcomes (Evidence: Moderate 3).
Use of Advanced Reconstructive Techniques: Employ flaps like radial forearm or FAP flaps for complex defects to enhance both function and aesthetics (Evidence: Moderate 23).
Adjuvant Radiation Therapy for High-Risk Features: Consider adjuvant radiation for tumors with deep invasion, positive margins, or lymphovascular emboli (Evidence: Moderate 3).
Regular Follow-Up: Schedule frequent follow-up visits, especially in the first two years post-treatment, to monitor for recurrence (Evidence: Moderate 3).
Patient Education on Self-Examination: Educate patients on recognizing early signs of recurrence or new lesions (Evidence: Expert opinion 3).
Avoid Unnecessary Undermining: Minimize undermining during primary closure to reduce postoperative complications (Evidence: Moderate 5).
Consider Multimodal Therapy for Advanced Cases: For advanced or metastatic disease, consult with oncologists for potential chemotherapy or combined modality therapy (Evidence: Weak 3).
Tailored Approaches for Special Populations: Adjust treatment strategies based on patient age, comorbidities, and specific risk factors (Evidence: Expert opinion 3).
Utilize Clinical Trials for Innovative Treatments: Engage in clinical trials for novel reconstructive techniques and adjuvant therapies when appropriate (Evidence: Expert opinion 1).References
1 Okifo O, Brown T, Boyd C. Clinical Trials in Facial Plastic and Reconstructive Surgery. Facial plastic surgery : FPS 2023. link
2 Grinsell D, Herle P. Composite pronator quadratus: radial forearm free flap in functional lip reconstruction. ANZ journal of surgery 2019. link
3 Aksam E, Demirseren ME, Aksam B, Demirseren DD, Inan HM. Sphincter-Sparing Excision and Reconstruction Using Facial Artery Perforator Flaps for Lower Lip Carcinoma. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2017. link
4 Rahpeyma A, Khajehahmadi S. Use of lower vermilion cross-lip flap for correction of whistle deformity in clinical practice and anatomic study for the secondary cleft lip repair. The Journal of craniofacial surgery 2013. link
5 Barry RB, McKenzie J, Berg D, Langtry JA. Direct primary closure without undermining in the repair of vermilionectomy defects of the lower lip. The British journal of dermatology 2012. link
6 Kuo YR, Jeng SF, Wei FC, Su CY, Chien CY. Functional reconstruction of complex lip and cheek defect with free composite anterolateral thigh flap and vascularized fascia. Head & neck 2008. link
7 Fisher GH, Geronemus RG, Bernstein L. Defect involving both the cutaneous and the vermilion lip. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2006. link